IO360° offers an opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting Immuno-Oncology (IO) to fight a wider range of cancers.
Lumanity will be speaking on a panel:
Wednesday, Feb 28, 2024, 11:50am-12:30pm
State of the IO Market, Investments, and Deals Continued: Investment Trends in IO
Connect with our staff or schedule a time to meet during the meeting by reaching out to email@example.com.